Under Trump's "drug price restraint", pharmaceutical stocks are in turmoil and the industry is in a state of competition
Recently, the US pharmaceutical market has been swept by a storm. Trump sent letters to 17 global pharmaceutical giants, demanding that they lower the prices of drugs in the United States within 60 days, or else he would resort to all means.
more